Avenue Therapeutics, Inc. (ATXI)
0.70
+0.03
(+4.48%)
USD |
OTCM |
Dec 24, 16:00
Avenue Therapeutics EPS Diluted (Quarterly): -0.2145 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -0.9442 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.692M |
| Total Expenses (Quarterly) | 0.683M |
| Enterprise Value | -2.735M |
| Earnings Yield | -209.3% |
| Normalized Earnings Yield | -210.36 |